Knight Therapeutics, Inc.

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil

Knight Therapeutics Reports First Quarter 2026 Results

Notice of Knight Therapeutics' First Quarter 2026 Results Conference Call

Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Knight Therapeutics Inc. ranks on The Globe and Mail's second annual Canada's Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity